Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Classifica tra le azioni #40869
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Prezzo delle azioni
$0.02765
Ultima sincronizzazione: 2024-12-23
Capitalizzazione di mercato
$69.04K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Histogen Inc. (HSTO)

Categoria

Storico del prezzo dell'azione per Histogen Inc. (HSTO)
Prezzo di chiusura più alto: $0.02 il 2024-12-01

Prezzo di chiusura più basso: $186.88 il 2013-07-01
Storico del prezzo dell'azione di Histogen Inc. dal 2013 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -28.82%
2023 -66.41%
2022 -88.05%
2021 -66.17%
2020 -68.37%
2019 -78.98%
2018 -59.92%
2017 45.54%
2016 4.61%
2015 -61.12%
2014 15.35%
2013 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$518.32 30.92%
US
$862.10 33.33%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE